Tern（QEG2）株式概要Tern Plcは、アーリーステージおよびグロースキャピタル投資を専門とするベンチャーキャピタルである。 詳細QEG2 ファンダメンタル分析スノーフレーク・スコア評価2/6将来の成長0/6過去の実績0/6財務の健全性2/6配当金0/6リスク分析過去1年間で株主の希薄化は大幅に進んだ 過去5年間で収益は年間41.4%減少しました。 German市場と比較して、過去 3 か月間の株価の変動が非常に大きい収益が 100 万ドル未満 ( £29K )+2 さらなるリスクすべてのリスクチェックを見るQEG2 Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair Value€Current Price€0.0005733.3% 割高 内在価値ディスカウントEst. Revenue$PastFuture-12m4m2016201920222025202620282031Revenue UK£13.1kEarnings UK£3.8kAdvancedSet Fair ValueView all narrativesTern Plc 競合他社DLB-AnlageserviceSymbol: BST:DLBMarket cap: €10.5mRM Rheiner ManagementSymbol: DUSE:RMOMarket cap: €7.8mArbitrage InvestmentSymbol: HMSE:L1AMarket cap: €9.5mtokentus investmentSymbol: XTRA:14DMarket cap: €6.4m価格と性能株価の高値、安値、推移の概要Tern過去の株価現在の株価UK£0.000552週高値UK£0.01652週安値UK£0.0005ベータ-0.361ヶ月の変化0%3ヶ月変化0%1年変化-95.00%3年間の変化-98.15%5年間の変化-99.76%IPOからの変化-99.59%最新ニュースお知らせ • May 20Tern Plc has completed a Follow-on Equity Offering in the amount of £0.222 million.Tern Plc has completed a Follow-on Equity Offering in the amount of £0.222 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 37,000,000 Price\Range: £0.006 Transaction Features: Subsequent Direct Listingお知らせ • May 08Tern Plc has completed a Follow-on Equity Offering in the amount of £0.405998 million.Tern Plc has completed a Follow-on Equity Offering in the amount of £0.405998 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 67,666,314 Price\Range: £0.006 Transaction Features: Rights Offeringお知らせ • Mar 03Tern Plc has completed a Follow-on Equity Offering in the amount of £0.312655 million.Tern Plc has completed a Follow-on Equity Offering in the amount of £0.312655 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 78,163,662 Price\Range: £0.004 Transaction Features: Rights Offeringお知らせ • Feb 13Tern Plc has filed a Follow-on Equity Offering in the amount of £0.384408 million.Tern Plc has filed a Follow-on Equity Offering in the amount of £0.384408 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 96,101,957 Price\Range: £0.004 Transaction Features: Rights Offeringお知らせ • Oct 01Tern Plc has filed a Follow-on Equity Offering in the amount of £0.642486 million.Tern Plc has filed a Follow-on Equity Offering in the amount of £0.642486 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 128,497,293 Price\Range: £0.005 Transaction Features: Rights Offeringお知らせ • Jul 30Tern Plc has completed a Follow-on Equity Offering in the amount of £0.642486 million.Tern Plc has completed a Follow-on Equity Offering in the amount of £0.642486 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 64,248,646 Price\Range: £0.01 Discount Per Security: £0.0009 Transaction Features: Rights Offering最新情報をもっと見るRecent updatesお知らせ • May 20Tern Plc has completed a Follow-on Equity Offering in the amount of £0.222 million.Tern Plc has completed a Follow-on Equity Offering in the amount of £0.222 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 37,000,000 Price\Range: £0.006 Transaction Features: Subsequent Direct Listingお知らせ • May 08Tern Plc has completed a Follow-on Equity Offering in the amount of £0.405998 million.Tern Plc has completed a Follow-on Equity Offering in the amount of £0.405998 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 67,666,314 Price\Range: £0.006 Transaction Features: Rights Offeringお知らせ • Mar 03Tern Plc has completed a Follow-on Equity Offering in the amount of £0.312655 million.Tern Plc has completed a Follow-on Equity Offering in the amount of £0.312655 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 78,163,662 Price\Range: £0.004 Transaction Features: Rights Offeringお知らせ • Feb 13Tern Plc has filed a Follow-on Equity Offering in the amount of £0.384408 million.Tern Plc has filed a Follow-on Equity Offering in the amount of £0.384408 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 96,101,957 Price\Range: £0.004 Transaction Features: Rights Offeringお知らせ • Oct 01Tern Plc has filed a Follow-on Equity Offering in the amount of £0.642486 million.Tern Plc has filed a Follow-on Equity Offering in the amount of £0.642486 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 128,497,293 Price\Range: £0.005 Transaction Features: Rights Offeringお知らせ • Jul 30Tern Plc has completed a Follow-on Equity Offering in the amount of £0.642486 million.Tern Plc has completed a Follow-on Equity Offering in the amount of £0.642486 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 64,248,646 Price\Range: £0.01 Discount Per Security: £0.0009 Transaction Features: Rights Offeringお知らせ • Jul 14Tern Plc has filed a Follow-on Equity Offering in the amount of £0.642486 million.Tern Plc has filed a Follow-on Equity Offering in the amount of £0.642486 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 64,248,646 Price\Range: £0.01 Discount Per Security: £0.0009 Transaction Features: Rights Offeringお知らせ • Jun 30Tern Plc Appoints Jane Mccracken as Interim ChairTern Plc announced that Jane McCracken, previously an independent Non-Executive Director of the Company, assumed the role of the Company's Chair at the conclusion of the AGM, initially on an interim basis. The Board of the Company now therefore comprises Jane McCracken (Independent Interim Non-Executive Chair) and Iain Ross (Independent Non-Executive Director). The Board will continue to be supported by a non-Board senior management team, led by Al Sisto and Bruce Leith.お知らせ • Jun 07Tern Plc, Annual General Meeting, Jun 30, 2025Tern Plc, Annual General Meeting, Jun 30, 2025. Location: the offices of allenby capital, 5 st helens place, ec3a 6ab, london United Kingdomお知らせ • Jun 06Tern PLC Announces Ian Ritchie Decides to Retire from its Board, Effective June 30, 2025Tern PLC announced that Ian Ritchie, who has been the Company's Non-Executive Chairman since 2017, has decided to retire from the Board at the conclusion of the AGM to be held on June 30, 2025.お知らせ • May 07Tern Plc has completed a Follow-on Equity Offering in the amount of £0.34014 million.Tern Plc has completed a Follow-on Equity Offering in the amount of £0.34014 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 34,013,989 Price\Range: £0.01 Transaction Features: Rights Offeringお知らせ • Apr 17Tern Plc has filed a Follow-on Equity Offering in the amount of £0.34014 million.Tern Plc has filed a Follow-on Equity Offering in the amount of £0.34014 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 34,013,989 Price\Range: £0.01 Transaction Features: Rights Offeringお知らせ • Feb 26Tern Plc has completed a Follow-on Equity Offering in the amount of £0.221154 million.Tern Plc has completed a Follow-on Equity Offering in the amount of £0.221154 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 19,230,769 Price\Range: £0.0115 Transaction Features: Subsequent Direct Listingお知らせ • Feb 21Tern Plc has filed a Follow-on Equity Offering in the amount of £0.221154 million.Tern Plc has filed a Follow-on Equity Offering in the amount of £0.221154 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 19,230,769 Price\Range: £0.0115 Transaction Features: Subsequent Direct Listingお知らせ • Dec 16Tern Plc has completed a Follow-on Equity Offering in the amount of £0.4 million.Tern Plc has completed a Follow-on Equity Offering in the amount of £0.4 million. Security Name: Shares Security Type: Common Stock Securities Offered: 30,769,231 Price\Range: £0.013 Transaction Features: Subsequent Direct ListingBoard Change • Nov 04Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 2 non-independent directors. Independent Non-Executive Chairman Ian Ritchie was the last independent director to join the board, commencing their role in 2017. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.お知らせ • Oct 30Tern plc Announces Board ChangesTern Plc announced a number of changes to the Company's Board of Directors (the "Board"). Tern announced the appointment of Jane Karwoski (known as "Jane McCracken") and Iain Ross as independent Non-Executive Directors of the Company with immediate effect. Sarah Payne and Alan Howarth have stepped down from the Board with immediate effect to concentrate on their other business interests. Following these changes the Board now comprises Ian Ritchie (Non-Executive Chairman), Jane McCracken (Non-Executive Director) and Iain Ross (Non-Executive Director). Jane McCracken has spent her career working with high growth technology businesses based in the USA. UK and Europe as an entrepreneur, investor, board member and advisor. Her experience covers a variety of areas including software, e-commerce, digital health and clinical research. She recently served as an Entrepreneur-in-Residence at the Advanced Technology Development Center, the state incubator based at Georgia Institute of Technology. She is the Chief Growth Officer for Corps Team, a US-based search and staffing firm supporting startups to the Fortune 500. Jane also serves on the board of London Stock Exchange Main Market listed Edinburgh Worldwide Investment Trust plc, which invests globally in high growth companies; and Radyus Research, a US-based privately held company that advises on drug discovery, lead candidate selection, and enabling studies. Iain Ross has over 40 years' experience in the international life sciences and technology sectors and has held significant roles in multi-national pharmaceutical and biotech companies. He has completed multiple financing transactions and has over 30 years' experience in cross-border management as a chairman or CEO. He has led or participated in eight IPOs and has direct experience of M&A transactions in Europe, the USA and the Pacific Rim. Currently he is Chairman of NASDAQ listed Silence Therapeutics plc, Executive Chairman of ReNeuron Group plc and internationally holds other non-executive director roles. Iain Ross joined the board of Redx Pharma plc on 1 May 2017. On 24 May 2017, Redx Pharma plc and Redx Oncology Ltd. were put into administration by Liverpool City Council, whilst Iain Ross was a director of both companies, as a result of non-payment of an outstanding loan of £2m. On 3 November 2017 Redx Pharma plc and Redx Oncology Ltd. exited administration with all creditors paid, under the Chairmanship of Iain Ross.Iain Ross was a director of Palla Pharma Limited, a company registered in Tasmania Australia, when it entered into administration on 17 December 2021. Subsequently in March 2022, a liquidator was appointed for a creditors' voluntary liquidation process. Iain Ross resigned from the board of Palla Pharma Limited on 20 April 2022. Iain Ross is Chairman of ReNeuron Group plc and director of its three subsidiaries, ReNeuron (UK) Limited, ReNeuron Holdings Limited, ReNeuron Limited, all of which entered into administration on 20 March 2024. This process is currently ongoing and Iain Ross remains the Chairman of ReNeuron Group plc and a director of the three above subsidiaries.New Risk • Sep 06New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -UK£1.0m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-UK£1.0m free cash flow). Share price has been highly volatile over the past 3 months (374% average daily change). Earnings have declined by 60% per year over the past 5 years. Revenue is less than US$1m (UK£41k revenue, or US$54k). Market cap is less than US$10m (€6.41m market cap, or US$7.12m). Minor Risk Shareholders have been diluted in the past year (11% increase in shares outstanding).Reported Earnings • Jun 04Full year 2023 earnings released: UK£0.032 loss per share (vs UK£0.029 loss in FY 2022)Full year 2023 results: UK£0.032 loss per share (further deteriorated from UK£0.029 loss in FY 2022). Net loss: UK£12.6m (loss widened 21% from FY 2022). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 30 percentage points per year, which is a significant difference in performance.お知らせ • May 31Tern Plc, Annual General Meeting, Jun 27, 2024Tern Plc, Annual General Meeting, Jun 27, 2024. Location: the offices of allenby capital, 5 st helens place, ec3a 6ab, london United KingdomBuy Or Sell Opportunity • Apr 26Now 99% overvalued after recent price riseOver the last 90 days, the stock has risen 36% to €0.022. The fair value is estimated to be €0.011, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 7.6% over the last 3 years. Meanwhile, the company became loss making.Buy Or Sell Opportunity • Mar 28Now 71% overvaluedOver the last 90 days, the stock has fallen 24% to €0.015. The fair value is estimated to be €0.0091, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 7.6% over the last 3 years. Meanwhile, the company became loss making.Buy Or Sell Opportunity • Mar 12Now 37% overvaluedOver the last 90 days, the stock has fallen 57% to €0.012. The fair value is estimated to be €0.0088, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 7.6% over the last 3 years. Meanwhile, the company became loss making.New Risk • Mar 03New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (53% average daily change). Earnings have declined by 41% per year over the past 5 years. Revenue is less than US$1m (UK£202k revenue, or US$256k). Market cap is less than US$10m (€9.09m market cap, or US$9.85m). Minor Risks Latest financial reports are more than 6 months old (reported June 2023 fiscal period end). Shareholders have been diluted in the past year (5.4% increase in shares outstanding).New Risk • Mar 01New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: €9.09m (US$9.83m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (53% average daily change). Earnings have declined by 41% per year over the past 5 years. Revenue is less than US$1m (UK£202k revenue, or US$255k). Market cap is less than US$10m (€9.09m market cap, or US$9.83m). Minor Risk Shareholders have been diluted in the past year (5.4% increase in shares outstanding).Buy Or Sell Opportunity • Feb 08Now 74% overvaluedOver the last 90 days, the stock has fallen 53% to €0.018. The fair value is estimated to be €0.01, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 7.6% over the last 3 years. Meanwhile, the company became loss making.New Risk • Jan 26New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 5.4% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (58% average weekly change). Earnings have declined by 41% per year over the past 5 years. Revenue is less than US$1m (UK£202k revenue, or US$257k). Minor Risks Shareholders have been diluted in the past year (5.4% increase in shares outstanding). Market cap is less than US$100m (€9.84m market cap, or US$10.7m).お知らせ • Jan 26Tern Plc has completed a Follow-on Equity Offering in the amount of £0.4 million.Tern Plc has completed a Follow-on Equity Offering in the amount of £0.4 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 20,000,000 Price\Range: £0.02 Transaction Features: Subsequent Direct ListingBuy Or Sell Opportunity • Jan 23Now 111% overvaluedOver the last 90 days, the stock has fallen 36% to €0.024. The fair value is estimated to be €0.011, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 7.6% over the last 3 years. Meanwhile, the company became loss making.New Risk • Dec 29New major risk - Revenue and earnings growthEarnings have declined by 41% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-UK£2.0m free cash flow). Share price has been highly volatile over the past 3 months (35% average weekly change). Earnings have declined by 41% per year over the past 5 years. Revenue is less than US$1m (UK£202k revenue, or US$257k). Minor Risk Market cap is less than US$100m (€15.1m market cap, or US$16.7m).New Risk • Dec 17New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2022. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (32% average weekly change). Revenue is less than US$1m (UK£66k revenue, or US$84k). Minor Risks Latest financial reports are more than 6 months old (reported December 2022 fiscal period end). Market cap is less than US$100m (€19.3m market cap, or US$21.0m).お知らせ • Aug 11+ 1 more updateTern plc Announces CFO ChangesTern Plc announced a number of changes to the board of the Company (the "Board") and the Company's management structure. Sarah Payne will step down as the Company's Chief Financial Officer and Company Secretary on or before 30 September 2023 to take up a position with another company, but will remain on the Board as a Non-Executive Director. A further announcement will be made when this change occurs. The Company expects to shortly appoint a part-time Chief Financial Officer, which will be a non-Board position. The Board will be supported by a non-Board senior executive management team comprising: Al Sisto (as Chief Executive Officer), Bruce Leith and a part-time Chief Financial Officer. The senior management team will receive materially reduced remuneration from the levels they received when members of the Board.Reported Earnings • Jun 01Full year 2022 earnings released: UK£0.029 loss per share (vs UK£0.013 profit in FY 2021)Full year 2022 results: UK£0.029 loss per share (down from UK£0.013 profit in FY 2021). Net loss: UK£10.4m (down 328% from profit in FY 2021).お知らせ • May 31Tern Plc, Annual General Meeting, Jun 29, 2023Tern Plc, Annual General Meeting, Jun 29, 2023, at 08:00 Coordinated Universal Time. Location: Reed Smith, The Broadgate Tower, 20 Primrose Street London United Kingdomお知らせ • May 23Tern Plc to Report Fiscal Year 2022 Final Results on May 31, 2023Tern Plc announced that they will report fiscal year 2022 final results on May 31, 2023Board Change • Nov 16Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 4 non-independent directors. Non-Executive Chairman & Senior Independent Director Ian Ritchie was the last independent director to join the board, commencing their role in 2017. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Reported Earnings • Sep 24First half 2022 earnings released: UK£0.007 loss per share (vs UK£0.002 loss in 1H 2021)First half 2022 results: UK£0.007 loss per share (further deteriorated from UK£0.002 loss in 1H 2021). Net loss: UK£2.41m (loss widened 236% from 1H 2021).Board Change • Apr 27Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 4 non-independent directors. Non-Executive Chairman & Senior Independent Director Ian Ritchie was the last independent director to join the board, commencing their role in 2017. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Reported Earnings • Mar 18Full year 2021 earnings: Revenues and EPS in line with analyst expectationsFull year 2021 results: EPS: UK£0.014 (up from UK£0.003 in FY 2020). Revenue: UK£6.10m (up UK£5.95m from FY 2020). Net income: UK£4.58m (up 470% from FY 2020). Profit margin: 75% (down from 532% in FY 2020). The decrease in margin was primarily driven by higher revenue. Revenue was in line with analyst estimates.Reported Earnings • Sep 16First half 2021 earnings released: UK£0.002 loss per share (vs UK£0.001 profit in 1H 2020)First half 2021 results: Net loss: UK£718.5k (down UK£860.9k from profit in 1H 2020).株主還元QEG2DE Capital MarketsDE 市場7D0%4.4%3.2%1Y-95.0%4.5%2.5%株主還元を見る業界別リターン: QEG2過去 1 年間で4.5 % の収益を上げたGerman Capital Markets業界を下回りました。リターン対市場: QEG2は、過去 1 年間で2.5 % のリターンを上げたGerman市場を下回りました。価格変動Is QEG2's price volatile compared to industry and market?QEG2 volatilityQEG2 Average Weekly Movement895.8%Capital Markets Industry Average Movement5.0%Market Average Movement6.1%10% most volatile stocks in DE Market13.3%10% least volatile stocks in DE Market2.7%安定した株価: QEG2の株価は、 German市場と比較して過去 3 か月間で変動しています。時間の経過による変動: QEG2の 週次ボラティリティ は、過去 1 年間で821%から896%に増加しました。会社概要設立従業員CEO（最高経営責任者ウェブサイト20046Al Sistowww.ternplc.comTern Plcは、アーリーステージおよびグロースキャピタル投資を専門とするベンチャーキャピタルである。同社は通常、IoTセキュリティ、人工知能（「AI」）、機械学習（「ML」）、仮想現実（「VR/AR」）、データサイエンス、イネーブルメント、ヘルスケアや産業分野向けの分析ソリューションを持つソフトウェア企業に投資している。主に英国を拠点とする企業に投資している。Tern Plcは英国ロンドンに拠点を置く。Tern Plcの前身はSilvermere Energy plc。もっと見るTern Plc 基礎のまとめTern の収益と売上を時価総額と比較するとどうか。QEG2 基礎統計学時価総額€8.92m収益（TTM）-€2.39m売上高(TTM)€34.05k261.9xP/Sレシオ-3.7xPER（株価収益率QEG2 は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計QEG2 損益計算書（TTM）収益UK£29.40k売上原価UK£0売上総利益UK£29.40kその他の費用UK£2.10m収益-UK£2.07m直近の収益報告Jun 30, 2025次回決算日該当なし一株当たり利益（EPS）-0.0024グロス・マージン100.00%純利益率-7,033.60%有利子負債／自己資本比率1.7%QEG2 の長期的なパフォーマンスは？過去の実績と比較を見るView Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/24 12:36終値2026/05/22 00:00収益2025/06/30年間収益2024/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Tern Plc 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
お知らせ • May 20Tern Plc has completed a Follow-on Equity Offering in the amount of £0.222 million.Tern Plc has completed a Follow-on Equity Offering in the amount of £0.222 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 37,000,000 Price\Range: £0.006 Transaction Features: Subsequent Direct Listing
お知らせ • May 08Tern Plc has completed a Follow-on Equity Offering in the amount of £0.405998 million.Tern Plc has completed a Follow-on Equity Offering in the amount of £0.405998 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 67,666,314 Price\Range: £0.006 Transaction Features: Rights Offering
お知らせ • Mar 03Tern Plc has completed a Follow-on Equity Offering in the amount of £0.312655 million.Tern Plc has completed a Follow-on Equity Offering in the amount of £0.312655 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 78,163,662 Price\Range: £0.004 Transaction Features: Rights Offering
お知らせ • Feb 13Tern Plc has filed a Follow-on Equity Offering in the amount of £0.384408 million.Tern Plc has filed a Follow-on Equity Offering in the amount of £0.384408 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 96,101,957 Price\Range: £0.004 Transaction Features: Rights Offering
お知らせ • Oct 01Tern Plc has filed a Follow-on Equity Offering in the amount of £0.642486 million.Tern Plc has filed a Follow-on Equity Offering in the amount of £0.642486 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 128,497,293 Price\Range: £0.005 Transaction Features: Rights Offering
お知らせ • Jul 30Tern Plc has completed a Follow-on Equity Offering in the amount of £0.642486 million.Tern Plc has completed a Follow-on Equity Offering in the amount of £0.642486 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 64,248,646 Price\Range: £0.01 Discount Per Security: £0.0009 Transaction Features: Rights Offering
お知らせ • May 20Tern Plc has completed a Follow-on Equity Offering in the amount of £0.222 million.Tern Plc has completed a Follow-on Equity Offering in the amount of £0.222 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 37,000,000 Price\Range: £0.006 Transaction Features: Subsequent Direct Listing
お知らせ • May 08Tern Plc has completed a Follow-on Equity Offering in the amount of £0.405998 million.Tern Plc has completed a Follow-on Equity Offering in the amount of £0.405998 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 67,666,314 Price\Range: £0.006 Transaction Features: Rights Offering
お知らせ • Mar 03Tern Plc has completed a Follow-on Equity Offering in the amount of £0.312655 million.Tern Plc has completed a Follow-on Equity Offering in the amount of £0.312655 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 78,163,662 Price\Range: £0.004 Transaction Features: Rights Offering
お知らせ • Feb 13Tern Plc has filed a Follow-on Equity Offering in the amount of £0.384408 million.Tern Plc has filed a Follow-on Equity Offering in the amount of £0.384408 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 96,101,957 Price\Range: £0.004 Transaction Features: Rights Offering
お知らせ • Oct 01Tern Plc has filed a Follow-on Equity Offering in the amount of £0.642486 million.Tern Plc has filed a Follow-on Equity Offering in the amount of £0.642486 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 128,497,293 Price\Range: £0.005 Transaction Features: Rights Offering
お知らせ • Jul 30Tern Plc has completed a Follow-on Equity Offering in the amount of £0.642486 million.Tern Plc has completed a Follow-on Equity Offering in the amount of £0.642486 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 64,248,646 Price\Range: £0.01 Discount Per Security: £0.0009 Transaction Features: Rights Offering
お知らせ • Jul 14Tern Plc has filed a Follow-on Equity Offering in the amount of £0.642486 million.Tern Plc has filed a Follow-on Equity Offering in the amount of £0.642486 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 64,248,646 Price\Range: £0.01 Discount Per Security: £0.0009 Transaction Features: Rights Offering
お知らせ • Jun 30Tern Plc Appoints Jane Mccracken as Interim ChairTern Plc announced that Jane McCracken, previously an independent Non-Executive Director of the Company, assumed the role of the Company's Chair at the conclusion of the AGM, initially on an interim basis. The Board of the Company now therefore comprises Jane McCracken (Independent Interim Non-Executive Chair) and Iain Ross (Independent Non-Executive Director). The Board will continue to be supported by a non-Board senior management team, led by Al Sisto and Bruce Leith.
お知らせ • Jun 07Tern Plc, Annual General Meeting, Jun 30, 2025Tern Plc, Annual General Meeting, Jun 30, 2025. Location: the offices of allenby capital, 5 st helens place, ec3a 6ab, london United Kingdom
お知らせ • Jun 06Tern PLC Announces Ian Ritchie Decides to Retire from its Board, Effective June 30, 2025Tern PLC announced that Ian Ritchie, who has been the Company's Non-Executive Chairman since 2017, has decided to retire from the Board at the conclusion of the AGM to be held on June 30, 2025.
お知らせ • May 07Tern Plc has completed a Follow-on Equity Offering in the amount of £0.34014 million.Tern Plc has completed a Follow-on Equity Offering in the amount of £0.34014 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 34,013,989 Price\Range: £0.01 Transaction Features: Rights Offering
お知らせ • Apr 17Tern Plc has filed a Follow-on Equity Offering in the amount of £0.34014 million.Tern Plc has filed a Follow-on Equity Offering in the amount of £0.34014 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 34,013,989 Price\Range: £0.01 Transaction Features: Rights Offering
お知らせ • Feb 26Tern Plc has completed a Follow-on Equity Offering in the amount of £0.221154 million.Tern Plc has completed a Follow-on Equity Offering in the amount of £0.221154 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 19,230,769 Price\Range: £0.0115 Transaction Features: Subsequent Direct Listing
お知らせ • Feb 21Tern Plc has filed a Follow-on Equity Offering in the amount of £0.221154 million.Tern Plc has filed a Follow-on Equity Offering in the amount of £0.221154 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 19,230,769 Price\Range: £0.0115 Transaction Features: Subsequent Direct Listing
お知らせ • Dec 16Tern Plc has completed a Follow-on Equity Offering in the amount of £0.4 million.Tern Plc has completed a Follow-on Equity Offering in the amount of £0.4 million. Security Name: Shares Security Type: Common Stock Securities Offered: 30,769,231 Price\Range: £0.013 Transaction Features: Subsequent Direct Listing
Board Change • Nov 04Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 2 non-independent directors. Independent Non-Executive Chairman Ian Ritchie was the last independent director to join the board, commencing their role in 2017. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
お知らせ • Oct 30Tern plc Announces Board ChangesTern Plc announced a number of changes to the Company's Board of Directors (the "Board"). Tern announced the appointment of Jane Karwoski (known as "Jane McCracken") and Iain Ross as independent Non-Executive Directors of the Company with immediate effect. Sarah Payne and Alan Howarth have stepped down from the Board with immediate effect to concentrate on their other business interests. Following these changes the Board now comprises Ian Ritchie (Non-Executive Chairman), Jane McCracken (Non-Executive Director) and Iain Ross (Non-Executive Director). Jane McCracken has spent her career working with high growth technology businesses based in the USA. UK and Europe as an entrepreneur, investor, board member and advisor. Her experience covers a variety of areas including software, e-commerce, digital health and clinical research. She recently served as an Entrepreneur-in-Residence at the Advanced Technology Development Center, the state incubator based at Georgia Institute of Technology. She is the Chief Growth Officer for Corps Team, a US-based search and staffing firm supporting startups to the Fortune 500. Jane also serves on the board of London Stock Exchange Main Market listed Edinburgh Worldwide Investment Trust plc, which invests globally in high growth companies; and Radyus Research, a US-based privately held company that advises on drug discovery, lead candidate selection, and enabling studies. Iain Ross has over 40 years' experience in the international life sciences and technology sectors and has held significant roles in multi-national pharmaceutical and biotech companies. He has completed multiple financing transactions and has over 30 years' experience in cross-border management as a chairman or CEO. He has led or participated in eight IPOs and has direct experience of M&A transactions in Europe, the USA and the Pacific Rim. Currently he is Chairman of NASDAQ listed Silence Therapeutics plc, Executive Chairman of ReNeuron Group plc and internationally holds other non-executive director roles. Iain Ross joined the board of Redx Pharma plc on 1 May 2017. On 24 May 2017, Redx Pharma plc and Redx Oncology Ltd. were put into administration by Liverpool City Council, whilst Iain Ross was a director of both companies, as a result of non-payment of an outstanding loan of £2m. On 3 November 2017 Redx Pharma plc and Redx Oncology Ltd. exited administration with all creditors paid, under the Chairmanship of Iain Ross.Iain Ross was a director of Palla Pharma Limited, a company registered in Tasmania Australia, when it entered into administration on 17 December 2021. Subsequently in March 2022, a liquidator was appointed for a creditors' voluntary liquidation process. Iain Ross resigned from the board of Palla Pharma Limited on 20 April 2022. Iain Ross is Chairman of ReNeuron Group plc and director of its three subsidiaries, ReNeuron (UK) Limited, ReNeuron Holdings Limited, ReNeuron Limited, all of which entered into administration on 20 March 2024. This process is currently ongoing and Iain Ross remains the Chairman of ReNeuron Group plc and a director of the three above subsidiaries.
New Risk • Sep 06New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -UK£1.0m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-UK£1.0m free cash flow). Share price has been highly volatile over the past 3 months (374% average daily change). Earnings have declined by 60% per year over the past 5 years. Revenue is less than US$1m (UK£41k revenue, or US$54k). Market cap is less than US$10m (€6.41m market cap, or US$7.12m). Minor Risk Shareholders have been diluted in the past year (11% increase in shares outstanding).
Reported Earnings • Jun 04Full year 2023 earnings released: UK£0.032 loss per share (vs UK£0.029 loss in FY 2022)Full year 2023 results: UK£0.032 loss per share (further deteriorated from UK£0.029 loss in FY 2022). Net loss: UK£12.6m (loss widened 21% from FY 2022). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 30 percentage points per year, which is a significant difference in performance.
お知らせ • May 31Tern Plc, Annual General Meeting, Jun 27, 2024Tern Plc, Annual General Meeting, Jun 27, 2024. Location: the offices of allenby capital, 5 st helens place, ec3a 6ab, london United Kingdom
Buy Or Sell Opportunity • Apr 26Now 99% overvalued after recent price riseOver the last 90 days, the stock has risen 36% to €0.022. The fair value is estimated to be €0.011, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 7.6% over the last 3 years. Meanwhile, the company became loss making.
Buy Or Sell Opportunity • Mar 28Now 71% overvaluedOver the last 90 days, the stock has fallen 24% to €0.015. The fair value is estimated to be €0.0091, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 7.6% over the last 3 years. Meanwhile, the company became loss making.
Buy Or Sell Opportunity • Mar 12Now 37% overvaluedOver the last 90 days, the stock has fallen 57% to €0.012. The fair value is estimated to be €0.0088, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 7.6% over the last 3 years. Meanwhile, the company became loss making.
New Risk • Mar 03New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (53% average daily change). Earnings have declined by 41% per year over the past 5 years. Revenue is less than US$1m (UK£202k revenue, or US$256k). Market cap is less than US$10m (€9.09m market cap, or US$9.85m). Minor Risks Latest financial reports are more than 6 months old (reported June 2023 fiscal period end). Shareholders have been diluted in the past year (5.4% increase in shares outstanding).
New Risk • Mar 01New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: €9.09m (US$9.83m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (53% average daily change). Earnings have declined by 41% per year over the past 5 years. Revenue is less than US$1m (UK£202k revenue, or US$255k). Market cap is less than US$10m (€9.09m market cap, or US$9.83m). Minor Risk Shareholders have been diluted in the past year (5.4% increase in shares outstanding).
Buy Or Sell Opportunity • Feb 08Now 74% overvaluedOver the last 90 days, the stock has fallen 53% to €0.018. The fair value is estimated to be €0.01, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 7.6% over the last 3 years. Meanwhile, the company became loss making.
New Risk • Jan 26New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 5.4% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (58% average weekly change). Earnings have declined by 41% per year over the past 5 years. Revenue is less than US$1m (UK£202k revenue, or US$257k). Minor Risks Shareholders have been diluted in the past year (5.4% increase in shares outstanding). Market cap is less than US$100m (€9.84m market cap, or US$10.7m).
お知らせ • Jan 26Tern Plc has completed a Follow-on Equity Offering in the amount of £0.4 million.Tern Plc has completed a Follow-on Equity Offering in the amount of £0.4 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 20,000,000 Price\Range: £0.02 Transaction Features: Subsequent Direct Listing
Buy Or Sell Opportunity • Jan 23Now 111% overvaluedOver the last 90 days, the stock has fallen 36% to €0.024. The fair value is estimated to be €0.011, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 7.6% over the last 3 years. Meanwhile, the company became loss making.
New Risk • Dec 29New major risk - Revenue and earnings growthEarnings have declined by 41% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-UK£2.0m free cash flow). Share price has been highly volatile over the past 3 months (35% average weekly change). Earnings have declined by 41% per year over the past 5 years. Revenue is less than US$1m (UK£202k revenue, or US$257k). Minor Risk Market cap is less than US$100m (€15.1m market cap, or US$16.7m).
New Risk • Dec 17New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2022. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (32% average weekly change). Revenue is less than US$1m (UK£66k revenue, or US$84k). Minor Risks Latest financial reports are more than 6 months old (reported December 2022 fiscal period end). Market cap is less than US$100m (€19.3m market cap, or US$21.0m).
お知らせ • Aug 11+ 1 more updateTern plc Announces CFO ChangesTern Plc announced a number of changes to the board of the Company (the "Board") and the Company's management structure. Sarah Payne will step down as the Company's Chief Financial Officer and Company Secretary on or before 30 September 2023 to take up a position with another company, but will remain on the Board as a Non-Executive Director. A further announcement will be made when this change occurs. The Company expects to shortly appoint a part-time Chief Financial Officer, which will be a non-Board position. The Board will be supported by a non-Board senior executive management team comprising: Al Sisto (as Chief Executive Officer), Bruce Leith and a part-time Chief Financial Officer. The senior management team will receive materially reduced remuneration from the levels they received when members of the Board.
Reported Earnings • Jun 01Full year 2022 earnings released: UK£0.029 loss per share (vs UK£0.013 profit in FY 2021)Full year 2022 results: UK£0.029 loss per share (down from UK£0.013 profit in FY 2021). Net loss: UK£10.4m (down 328% from profit in FY 2021).
お知らせ • May 31Tern Plc, Annual General Meeting, Jun 29, 2023Tern Plc, Annual General Meeting, Jun 29, 2023, at 08:00 Coordinated Universal Time. Location: Reed Smith, The Broadgate Tower, 20 Primrose Street London United Kingdom
お知らせ • May 23Tern Plc to Report Fiscal Year 2022 Final Results on May 31, 2023Tern Plc announced that they will report fiscal year 2022 final results on May 31, 2023
Board Change • Nov 16Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 4 non-independent directors. Non-Executive Chairman & Senior Independent Director Ian Ritchie was the last independent director to join the board, commencing their role in 2017. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Reported Earnings • Sep 24First half 2022 earnings released: UK£0.007 loss per share (vs UK£0.002 loss in 1H 2021)First half 2022 results: UK£0.007 loss per share (further deteriorated from UK£0.002 loss in 1H 2021). Net loss: UK£2.41m (loss widened 236% from 1H 2021).
Board Change • Apr 27Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 4 non-independent directors. Non-Executive Chairman & Senior Independent Director Ian Ritchie was the last independent director to join the board, commencing their role in 2017. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Reported Earnings • Mar 18Full year 2021 earnings: Revenues and EPS in line with analyst expectationsFull year 2021 results: EPS: UK£0.014 (up from UK£0.003 in FY 2020). Revenue: UK£6.10m (up UK£5.95m from FY 2020). Net income: UK£4.58m (up 470% from FY 2020). Profit margin: 75% (down from 532% in FY 2020). The decrease in margin was primarily driven by higher revenue. Revenue was in line with analyst estimates.
Reported Earnings • Sep 16First half 2021 earnings released: UK£0.002 loss per share (vs UK£0.001 profit in 1H 2020)First half 2021 results: Net loss: UK£718.5k (down UK£860.9k from profit in 1H 2020).
